Fingerprint
Dive into the research topics of 'Talimogene laherparepvec in combination with ipilimumab versus ipilimumab alone for advanced melanoma: 5-year final analysis of a multicenter, randomized, open-label, phase II trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically